Liabilities / Assets
68th percentile
Higher debt load relative to assets than 68% of similar nonprofits.
990 • Fiscal year 2016 • EIN 47-2277599
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
68th percentile
Higher debt load relative to assets than 68% of similar nonprofits.
Liabilities / Revenue
71st percentile
Higher debt load relative to revenue than 71% of similar nonprofits.
Net Margin
87th percentile
Higher net margin than 87% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
87th percentile
Faster asset growth than 87% of similar nonprofits.
Revenue Growth
86th percentile
Faster revenue growth than 86% of similar nonprofits.
Assets
Up$197,421
Up $75,146 (+61%) from 2015
Net Assets
Up$192,144
Up $69,869 (+57%) from 2015
Liabilities
Up$5,277
Up $5,277 from 2015
Revenue
Up$193,677
Up $62,835 (+48%) from 2015
Expenses
Up$123,808
Up $114,971 (+1301%) from 2015
Net Income
Down$69,869
Down $52,136 (-43%) from 2015
This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The foundation's mission is to advocate for greater access to advanced therapies, such as cell and gene therapies, and provide support to individuals affected by cancer and rare disease. Support includes education, emotional support, connections to treatment centers and clinical trials, and comfort packages.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2016 • Form 990Summary only. Only limited summary data is available for this year.